edotreotide has been researched along with Carcinoma, Renal Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fabritius, MP; Mansour, N; Rangan, K; Rübenthaler, J; Tiling, R | 1 |
1 other study(ies) available for edotreotide and Carcinoma, Renal Cell
| Article | Year |
|---|---|
68 Ga-DOTATOC PET/CT in Pancreatic Metastasis From Clear Cell Renal Cell Carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |